Latest News and Press Releases
Want to stay updated on the latest news?
-
Shire Announces FDA Approval for Label Expansion of CINRYZE® (C1 esterase inhibitor [human]) for Prevention of Attacks in Pediatric Hereditary Angioedema Patients CINRYZE is the first and only...
-
LEXINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products for critical unmet needs in healthcare,...
-
WATERTOWN, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...
-
SEB:s Boprisindikator backar i juni. Nedgången är 4 enheter från föregående månad och indikatorn är nu 7. Bland regionerna uppvisar Stockholm åter en negativ siffra, minus 7. Övriga regioner...
-
Poster presentations will include new analysis of efficacy against drug resistant S. aureus in skin infections BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc....
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis beginnt US-Vermarktung von...
-
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Curetis Launches Unyvero System and...
-
BEDMINSTER, N.J., June 06, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing...
-
GAITHERSBURG, Md., June 05, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that data on its Acuitas® AMR Gene Panel u5.47 (RUO) and Acuitas Lighthouse® Knowledgebase will be...
-
Eighteen presentations with data across multiple pipeline candidates including data supporting SPR994’s broad spectrum of activity and equivalence to IV carbapenems CAMBRIDGE, Mass., June 05, 2018 ...